Dr. Joachim Müller
chief of service
Radiologie und Nuklearmedizin · Dept. IV
Unusually Aggressive Presentation of Malignant Peritoneal Mesothelioma: Two Case Reports.
Neff D, Padberg Sgier B, Dietze H, Müller J, Früh M. Unusually Aggressive Presentation of Malignant Peritoneal Mesothelioma: Two Case Reports. Case Rep Oncol 2022; 15:1001-1008.
Nov 8, 2022Unusually Aggressive Presentation of Malignant Peritoneal Mesothelioma: Two Case Reports.
Nov 8, 2022Case Rep Oncol 2022; 15:1001-1008
Neff Dominik, Padberg Sgier Barbara-Christina, Dietze Hannah, Müller Joachim, Früh Martin
Focal unspecific bone uptake on [F]-PSMA-1007 PET: a multicenter retrospective evaluation of the distribution, frequency, and quantitative parameters of a potential pitfall in prostate cancer imaging
Grünig H, Maurer A, Thali Y, Kovacs Z, Strobel K, Burger I, Müller J. Focal unspecific bone uptake on [F]-PSMA-1007 PET: a multicenter retrospective evaluation of the distribution, frequency, and quantitative parameters of a potential pitfall in prostate cancer imaging. Eur J Nucl Med Mol Imaging 2021; 48:4483-4494.
Jun 13, 2021Focal unspecific bone uptake on [F]-PSMA-1007 PET: a multicenter retrospective evaluation of the distribution, frequency, and quantitative parameters of a potential pitfall in prostate cancer imaging
Jun 13, 2021Eur J Nucl Med Mol Imaging 2021; 48:4483-4494
Grünig Hannes, Maurer Alexander, Thali Yannick, Kovacs Zsofia, Strobel Klaus, Burger Irene A, Müller Joachim
Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients
Hasan Ali O, Hundsberger T, Diem S, Müller S, Pop O, Markert E, Müller J, Moulin A, Ring S, Ackermann C, Berner F, Flatz L. Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients. Cancer Immunol Immunother 2020; 70:563-568.
Aug 17, 2020Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients
Aug 17, 2020Cancer Immunol Immunother 2020; 70:563-568
Hasan Ali Omar, Hundsberger Thomas, Diem Stefan, Müller Stefanie, Pop Oltin, Markert Eva, Müller Joachim, Moulin Alexandre, Ring Sandra, Ackermann Christoph Jakob, Berner Fiamma, Flatz Lukas
Radiation dosimetry of 18F-AzaFol: A first inhuman use of a folate receptor PET tracer
Müller J, Früh M, Siano M. Radiation dosimetry of 18F-AzaFol: A first inhuman use of a folate receptor PET tracer. EJNMMI Research 2020; 10
Apr 8, 2020Radiation dosimetry of 18F-AzaFol: A first inhuman use of a folate receptor PET tracer
Apr 8, 2020EJNMMI Research 2020; 10
Müller Joachim, Früh Martin, Siano Marco
Radiation dosimetry of F-AzaFol: A first in-human use of a folate receptor PET tracer
Gnesin S, Prior J, Treyer V, Kaufmann P, Ametamey S, Schibli R, Müller C, Choschzick M, Früh M, Siano M, Meisel A, Burger I, Müller J, Schaefer N. Radiation dosimetry of F-AzaFol: A first in-human use of a folate receptor PET tracer. EJNMMI Res 2020; 10:32.
Apr 8, 2020Radiation dosimetry of F-AzaFol: A first in-human use of a folate receptor PET tracer
Apr 8, 2020EJNMMI Res 2020; 10:32
Gnesin Silvano, Prior John O, Treyer Valerie, Kaufmann Philipp A, Ametamey Simon M, Schibli Roger, Müller Cristina, Choschzick Matthias, Früh Martin, Siano Marco, Meisel Alexander, Burger Irene A, Müller Joachim, Schaefer Niklaus
Is There a Flare Phenomenon on Bone Scintigraphy in Men With Advanced Prostate Cancer Treated With Radium-223?
Isensee G, Péporté A, Müller J, Schmid S, Gillessen Sommer S, Omlin A. Is There a Flare Phenomenon on Bone Scintigraphy in Men With Advanced Prostate Cancer Treated With Radium-223?. Clin Genitourin Cancer 2018; 16:349-354.
Apr 23, 2018Is There a Flare Phenomenon on Bone Scintigraphy in Men With Advanced Prostate Cancer Treated With Radium-223?
Apr 23, 2018Clin Genitourin Cancer 2018; 16:349-354
Isensee Gesa, Péporté Anne, Müller Joachim, Schmid Sabine, Gillessen Sommer Silke, Omlin Aurelius
Treatment of limited disease small cell lung cancer: the multidisciplinary team
Glatzer M, Rittmeyer A, Müller J, Opitz I, Papachristofilou A, Psallidas I, Früh M, Born D, Putora P. Treatment of limited disease small cell lung cancer: the multidisciplinary team. Eur Respir J. 2017; 50
Aug 24, 2017Treatment of limited disease small cell lung cancer: the multidisciplinary team
Aug 24, 2017Eur Respir J. 2017; 50
Glatzer Markus, Rittmeyer Achim, Müller Joachim, Opitz Isabelle, Papachristofilou Alexandros, Psallidas Ioannis, Früh Martin, Born Diana, Putora Paul Martin
Early Postoperative FDG-PET-CT Imaging Results in a Relevant Upstaging in the pN2 Subgroup of Stage III Colorectal Cancer Patients
Fehr M, Müller J, Knitel M, Fornaro J, Horber D, Koeberle D, Cerny T, Gueller U. Early Postoperative FDG-PET-CT Imaging Results in a Relevant Upstaging in the pN2 Subgroup of Stage III Colorectal Cancer Patients. Clin Colorectal Cancer 2017
Mar 21, 2017Early Postoperative FDG-PET-CT Imaging Results in a Relevant Upstaging in the pN2 Subgroup of Stage III Colorectal Cancer Patients
Mar 21, 2017Clin Colorectal Cancer 2017
Fehr Martin, Müller Joachim, Knitel Meinhard, Fornaro Jürgen, Horber Daniel, Koeberle Dieter, Cerny Thomas, Gueller Ulrich
SUVmax and Tumour Location in PET-CT Predict Oncogene Status in Lung Cancer
Putora P, Szentesi K, Glatzer M, Rodriguez R, Müller J, Baty F, Früh M. SUVmax and Tumour Location in PET-CT Predict Oncogene Status in Lung Cancer. Oncol Res Treat 2016; 39:681-686.
Oct 19, 2016SUVmax and Tumour Location in PET-CT Predict Oncogene Status in Lung Cancer
Oct 19, 2016Oncol Res Treat 2016; 39:681-686
Putora Paul Martin, Szentesi Kinga, Glatzer Markus, Rodriguez Regulo, Müller Joachim, Baty Florent, Früh Martin
GLUT1-positive recurrent basal cell carcinoma of basosquamous subtype detected by positron emission tomography
Hasan Ali O, Diem S, Aschwanden J, Markert E, Tasman A, Müller J, Flatz L. GLUT1-positive recurrent basal cell carcinoma of basosquamous subtype detected by positron emission tomography. JAAD Case Rep 2016; 2:415-417.
Oct 13, 2016GLUT1-positive recurrent basal cell carcinoma of basosquamous subtype detected by positron emission tomography
Oct 13, 2016JAAD Case Rep 2016; 2:415-417
Hasan Ali Omar, Diem Stefan, Aschwanden Josef, Markert Eva, Tasman Abel-Jan, Müller Joachim, Flatz Lukas
Case report: radio-supersensitive oligometastatic lung cancer
Glatzer M, Putora P, Müller J, Minervini F, Plasswilm L (2016). Case report: radio-supersensitive oligometastatic lung cancer.
Aug 25, 2016Case report: radio-supersensitive oligometastatic lung cancer
Aug 25, 2016SASRO 2016
Glatzer Markus, Putora Paul Martin, Müller Joachim, Minervini F, Plasswilm Ludwig
Sentinel lymph node biopsy in endometrial and cervical cancers using freehand SPECT - first experiences
Markus A, Ray A, Bolla D, Müller J, Diener P, Wendler T, Hornung R. Sentinel lymph node biopsy in endometrial and cervical cancers using freehand SPECT - first experiences. Gynecol Surg 2016; 13:499-506.
Aug 2, 2016Sentinel lymph node biopsy in endometrial and cervical cancers using freehand SPECT - first experiences
Aug 2, 2016Gynecol Surg 2016; 13:499-506
Markus Alexander, Ray Alessandra Sophia Carmen, Bolla Daniele, Müller Joachim, Diener Pierre-André, Wendler Thomas, Hornung René
Handheld single photon emission computed tomography (handheld SPECT) navigated video-assisted thoracoscopic surgery of computer tomography-guided radioactively marked pulmonary lesions
Müller J, Putora P, Schneider T, Zeisel C, Brutsche M, Bartz-Batliner M, Markus A, Kick J. Handheld single photon emission computed tomography (handheld SPECT) navigated video-assisted thoracoscopic surgery of computer tomography-guided radioactively marked pulmonary lesions. Interact Cardiovasc Thorac Surg 2016; 23:345-350.
May 20, 2016Handheld single photon emission computed tomography (handheld SPECT) navigated video-assisted thoracoscopic surgery of computer tomography-guided radioactively marked pulmonary lesions
May 20, 2016Interact Cardiovasc Thorac Surg 2016; 23:345-350
Müller Joachim, Putora Paul Martin, Schneider Tino, Zeisel C, Brutsche Martin, Bartz-Batliner Mira, Markus Alexander, Kick Jochen
Vemurafenib-related sterile scrotal abscess in a patient with BRAFV600K-mutant advanced melanoma mimicking distant metastasis
Marsico J, Rodriguez R, Müller J, Jörger M. Vemurafenib-related sterile scrotal abscess in a patient with BRAFV600K-mutant advanced melanoma mimicking distant metastasis. J Cancer Res Ther 2015; 11:647.
Jul 1, 2015Vemurafenib-related sterile scrotal abscess in a patient with BRAFV600K-mutant advanced melanoma mimicking distant metastasis
Jul 1, 2015J Cancer Res Ther 2015; 11:647
Marsico Jennifer Gibbons, Rodriguez Regulo, Müller Joachim, Jörger Markus
Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer
Niederer-Wuest S, Stöckli S, ess s, Haile S, Müller J, Oettli R, Clerici T, Bilz S, Brändle M, Förbs D, Jochum W, Broglie Däppen M. Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer. Surgery 2015; 157:119-25.
Jan 1, 2015Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer
Jan 1, 2015Surgery 2015; 157:119-25
Niederer-Wuest Severine, Stöckli Sandro, ess silvia, Haile Sarah, Müller Joachim, Oettli Rene, Clerici Thomas, Bilz Stefan, Brändle Michael, Förbs Diana, Jochum Wolfram, Broglie Däppen Martina
Pulmonary embolism in a patient with primary renal synovial sarcoma: the important differential diagnosis of tumor embolism and its therapeutic implications
Schmid S, Öhlschlegel C, Nagel W, Zeisel C, Müller J, Rothermundt C. Pulmonary embolism in a patient with primary renal synovial sarcoma: the important differential diagnosis of tumor embolism and its therapeutic implications. Case Rep Oncol 2013; 6:331-8.
Jun 22, 2013Pulmonary embolism in a patient with primary renal synovial sarcoma: the important differential diagnosis of tumor embolism and its therapeutic implications
Jun 22, 2013Case Rep Oncol 2013; 6:331-8
Schmid Sabine, Öhlschlegel Christian, Nagel Wolfgang, Zeisel Christoph, Müller Joachim, Rothermundt Christian
FDG-PET SUV-max values do not correlate with epidermal growth factor receptor mutation status in lung adenocarcinoma
Putora P, Früh M, Müller J. FDG-PET SUV-max values do not correlate with epidermal growth factor receptor mutation status in lung adenocarcinoma. Respirology 2013; 18:734-5.
May 1, 2013FDG-PET SUV-max values do not correlate with epidermal growth factor receptor mutation status in lung adenocarcinoma
May 1, 2013Respirology 2013; 18:734-5
Putora Paul Martin, Früh Martin, Müller Joachim
Relevance of incidental colorectal FDG-PET/CT-enhanced lesions
Putora P, Müller J, Borovicka J, Plasswilm L, Schmidt F. Relevance of incidental colorectal FDG-PET/CT-enhanced lesions. Onkologie 2013; 36:200-4.
Mar 18, 2013Relevance of incidental colorectal FDG-PET/CT-enhanced lesions
Mar 18, 2013Onkologie 2013; 36:200-4
Putora Paul Martin, Müller Joachim, Borovicka Jan, Plasswilm Ludwig, Schmidt Felix
Post Irradiation Sign of Progress in Anaplastic Ependymoma - A Case Report
Horstkemper R, Brügge D, Müller J, Mock B, Plasswilm L (2012). Post Irradiation Sign of Progress in Anaplastic Ependymoma - A Case Report.
Apr 20, 2012Post Irradiation Sign of Progress in Anaplastic Ependymoma - A Case Report
Apr 20, 2012SASRO 2012
Horstkemper Ruth, Brügge Detlef, Müller Joachim, Mock B, Plasswilm Ludwig
Radiotherapy with 3Gy for Inflammation due to Heterotopic Ossifications
Putora P, Horstkemper R, Müller J, Plasswilm L (2012). Radiotherapy with 3Gy for Inflammation due to Heterotopic Ossifications.
Apr 19, 2012Radiotherapy with 3Gy for Inflammation due to Heterotopic Ossifications
Apr 19, 2012SASRO 2012
Putora Paul Martin, Horstkemper Ruth, Müller Joachim, Plasswilm Ludwig